Logo-apb
Adv Pharm Bull. 2021;11(4): 632-642. doi: 10.34172/apb.2021.072
PMID: 34888210        PMCID: PMC8642803

Research Article

A Novel Approach for Development of Intraocular Biodegradable Ranibizumab Implant: A Solution for Stability of Protein Activity

Fatemeh Dadgar Pakdel 1,2 ORCID, Ahmad Mirshahi 3, Payam Zahedi 4, Kazem Mohammad 5, Farkhondeh Hemmati 6, Javad Dadgar Pakdel 7, Mohammad Hossein Nicknam 1,8 * ORCID, Farid Abedin Dorkoosh 2,9 * ORCID

Cited by CrossRef: 3


1- Wang L, Zhang H. Ocular barriers as a double-edged sword: preventing and facilitating drug delivery to the retina. Drug Deliv and Transl Res. 2023;13(2):547 [Crossref]
2- Pakdel F, Pakdel J, Najmeddin A, Peirovi A, Nicknam M, Dorkoosh F. A novel controlled release implant of insulin based on Poly (3- hydroxybutyrate-co-3-hydroxyvalerate) polymer prepared by extrusion process. tjps. 2023;0(0):0 [Crossref]
3- Chacin Ruiz E, Swindle-Reilly K, Ford Versypt A. Experimental and mathematical approaches for drug delivery for the treatment of wet age-related macular degeneration. Journal of Controlled Release. 2023;363:464 [Crossref]
4- Wang H, Song M, Xu J, Liu Z, Peng M, Qin H, Wang S, Wang Z, Liu K. Long-Acting Strategies for Antibody Drugs: Structural Modification, Controlling Release, and Changing the Administration Route. Eur J Drug Metab Pharmacokinet. 2024;49(3):295 [Crossref]